These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3051618)

  • 1. [Multiple sclerosis: an update].
    Duquette P
    Union Med Can; 1988 Aug; 118(3):231-5. PubMed ID: 3051618
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immunity in multiple sclerosis. Implications for pathogenesis and treatment.
    Thompson RF; Davenport J
    Mo Med; 1984 Oct; 81(10):669-73. PubMed ID: 6092887
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U; Majeron M; Mascetti A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of multiple sclerosis.
    Poser CM
    Compr Ther; 1981 Apr; 7(4):53-9. PubMed ID: 6263543
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple sclerosis].
    Steck AJ
    Rev Med Suisse Romande; 1984 Mar; 104(3):231-8. PubMed ID: 6326241
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic aspects of multiple sclerosis].
    Gonsette RE
    Bull Soc Belge Ophtalmol; 1982; 199-200():275-80. PubMed ID: 7184504
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S; Hohlfeld R
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract]   [Full Text] [Related]  

  • 9. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
    Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
    Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple sclerosis. Studies on etiology and therapy].
    Bauer HJ
    MMW Munch Med Wochenschr; 1982 Jan; 124(4):69-70. PubMed ID: 6801481
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical spectrum of multiple sclerosis.
    Reder AT; Antel JP
    Neurol Clin; 1983 Aug; 1(3):573-99. PubMed ID: 6095009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple sclerosis--an enigmatic disease].
    Schrader A
    Offentl Gesundheitswes; 1981 Aug; 43(8):360-4. PubMed ID: 6285239
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis: early management.
    Zajicek J
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):137-40. PubMed ID: 9166373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic trials in multiple sclerosis.
    Noseworthy JH; Seland TP; Ebers GC
    Can J Neurol Sci; 1984 Aug; 11(3):355-62. PubMed ID: 6205737
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppressive treatment in multiple sclerosis].
    Vermeulen M; Zegerius L; van Crevel H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological treatment of multiple sclerosis. II.
    Hughes RA
    J Neurol; 1986 Apr; 233(2):66-8. PubMed ID: 3009722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical picture and therapy of multiple sclerosis].
    Schrader A
    Wien Med Wochenschr; 1972 Mar; 122(10):129-34. PubMed ID: 4334261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
    Meyer-Rienecker H; Hitzschke B
    Nervenarzt; 1974 Mar; 45(3):133-41. PubMed ID: 4598802
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunological basis of current and novel therapies of multiple sclerosis.
    Dubois B; Opdenakker G
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):7-16. PubMed ID: 11729832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.